Nasdaq

AbbVie : FDA Oks Expanded BOTOX Label To Include Eight New Muscles To Treat Upper Limb Spasticity

(RTTNews) - Allergan, an AbbVie (ABBV) company, said that the U.S. Food and Drug Administration has approved a label expansion of BOTOX to include eight new muscles for the treatment of upper limb ...
Monthly Prescribing Reference

Botox Approval Expanded to Include 8 New Muscles for Upper Limb Spasticity

The indication for adult upper limb spasticity treatment now includes elbow and forearm muscles, intrinsic hand muscles, and thumb muscles. The Food and Drug Administration (FDA) has expanded the ...
Healio

FDA approves Botox label expansion for adult upper limb spasticity

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a label expansion for Botox to include eight new muscles and the use of ultrasound for the ...
Nature

Muscle Variants and Anatomical Relationships in the Upper Limb

The upper limb exhibits a remarkable degree of anatomical variation in muscle morphology, impacting both clinical management and surgical approaches. Variations such as ectopic insertions and ...
Nasdaq

FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

-- BOTOX® has demonstrated efficacy and has an established safety profile with over 10 years of clinical use in adult upper limb spasticity NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ -- Allergan, ...